Country: Írland
Tungumál: enska
Heimild: HPRA (Health Products Regulatory Authority)
GLUCOSAMINE SULPHATE SODIUM CHLORIDE
FMC Pharma Ltd
750 Milligram
Film Coated Tablet
2011-08-26
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Glusamin 750mg Film-coated Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 942mg glucosamine sulfate sodium chloride equivalent to 750mg glucosamine sulfate. Excipients: Each tablet contains 75.9mg (3.3 mmol) of sodium. Lactose monohydrate 3.0mg For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Film-coated tablet Off-white, oblong-shaped, film-coated tablet. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Glusamin tablets are indicated for the treatment of osteoarthritis of low to moderate degree. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _Administration:_ Glusamin tablets should be swallowed whole. _Adults and the elderly_: One Glusamin tablet should be taken twice daily. Or Two Glusamin tablets to be taken once daily Efficacy of glucosamine has been demonstrated for periods of up to three months, with a residual effect evident for two months after drug withdrawal. The safety and efficacy of the product were also confirmed in pivotal clinical trials for treatment up to three years. Continuous treatment beyond 3 years cannot be recommended as the safety has not been established beyond this period. _Children:_ Safety and efficacy has not been established in children, therefore, Glusamin tablets should not be used in persons under the age of 18 years. _Impaired renal and/or liver function._ In patients with impaired renal and/or liver function no dose recommendations can be given, since no studies have been performed. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 05/09/2011_ _CRN 2105113_ _page number: 1_ 4.3 CONTRAINDICATIONS Known sensitivity to glucosamine (or any of its derivat Lestu allt skjalið